Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

208 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Unproven Therapies for Diabetes and Their Implications.
Kesavadev J, Saboo B, Sadikot S, Das AK, Joshi S, Chawla R, Thacker H, Shankar A, Ramachandran L, Kalra S. Kesavadev J, et al. Among authors: thacker h. Adv Ther. 2017 Jan;34(1):60-77. doi: 10.1007/s12325-016-0439-x. Epub 2016 Nov 18. Adv Ther. 2017. PMID: 27864668 Free PMC article. Review.
Rationale, study design and methodology of the LANDMARC trial: a 3-year, pan-India, prospective, longitudinal study to assess management and real-world outcomes of diabetes mellitus.
Das AK, Mithal A, Kumar KMP, Unnikrishnan AG, Kalra S, Thacker H, Sethi B, Ghosh R, Mathew A, Chodankar D, Mohanasundaram S, Menon SK, Trivedi C, Naqvi M, Kanade V, Salvi V, Chatterjee G, Rais N, Wangnoo SK, Chowdhury S, Zargar AH, Joshi S. Das AK, et al. Among authors: thacker h. Diabet Med. 2020 May;37(5):885-892. doi: 10.1111/dme.14171. Epub 2019 Dec 15. Diabet Med. 2020. PMID: 31691356 Free PMC article.
Baseline characteristics of participants in the LANDMARC trial: A 3-year, pan-india, prospective, longitudinal study to assess management and real-world outcomes of diabetes mellitus.
Das AK, Mithal A, Joshi S, Kumar KMP, Kalra S, Unnikrishnan AG, Thacker H, Sethi B, Ghosh R, Kanade V, Nair A, Mohanasundaram S, Menon SK, Chodankar D, Salvi V, Trivedi C, Chatterjee G, Chowdhury S, Rais N, Wangnoo SK, Zargar AH. Das AK, et al. Among authors: thacker h. Endocrinol Diabetes Metab. 2021 Feb 8;4(3):e00231. doi: 10.1002/edm2.231. eCollection 2021 Jul. Endocrinol Diabetes Metab. 2021. PMID: 34277959 Free PMC article.
One-year trends from the LANDMARC trial: A 3-year, pan-India, prospective, longitudinal study on the management and real-world outcomes of type 2 diabetes mellitus.
Das AK, Kalra S, Joshi S, Mithal A, Kumar K M P, Unnikrishnan AG, Thacker H, Sethi B, Chowdhury S, Ghosh R, Krishnan S, Nair A, Mohanasundaram S, Menon SK, Salvi V, Chodankar D, Thaker S, Trivedi C, Wangnoo SK, Zargar AH, Rais N. Das AK, et al. Among authors: thacker h. Endocrinol Diabetes Metab. 2022 Jan;5(1):e00316. doi: 10.1002/edm2.316. Epub 2021 Dec 1. Endocrinol Diabetes Metab. 2022. PMID: 34856077 Free PMC article.
Two-year trends from the LANDMARC study: A 3-year, pan-India, prospective, longitudinal study on the management and real-world outcome in patients with type 2 diabetes mellitus.
Das AK, Kalra S, Joshi S, Mithal A, Kumar K M P, Unnikrishnan AG, Thacker H, Sethi B, Chowdhury S, Sugumaran A, Mohanasundaram S, Menon SK, Salvi V, Chodankar D, Thaker S, Trivedi C, Wangnoo SK, Zargar AH, Rais N. Das AK, et al. Among authors: thacker h. Endocrinol Diabetes Metab. 2023 Mar;6(2):e404. doi: 10.1002/edm2.404. Epub 2023 Feb 1. Endocrinol Diabetes Metab. 2023. PMID: 36722454 Free PMC article.
The LongitudinAl Nationwide stuDy on Management And Real-world outComes of diabetes in India over 3 years (LANDMARC trial).
Das AK, Kalra S, Joshi S, Mithal A, Kumar KMP, Unnikrishnan AG, Thacker H, Sethi B, Chowdhury S, Sugumaran A, Satpathy A, Gadekar A, Menon SK, Neogi R, Chodankar D, Trivedi C, Wangnoo SK, Zargar AH, Rais N; LANDMARC study group. Das AK, et al. Among authors: thacker h. Endocrinol Diabetes Metab. 2023 Sep;6(5):e422. doi: 10.1002/edm2.422. Epub 2023 Jul 1. Endocrinol Diabetes Metab. 2023. PMID: 37392036 Free PMC article.
SGLT2i as a First-line Antihyperglycemic in the Management of Type 2 Diabetes in the Context of Indians: A Systematic Review and Consensus.
Singh AK, Misra A, Das AK, Behl A, Srivastava A, Paneerselvam A, Chidambaram B, Saboo B, Sethi B, Makkar BM, Bantwal G, Thacker H, Panda J, Kesavadev J, Seshadri KG, Tiwaskar M, Shunmugavelu M, Sahay R, Das S, Agarwal S, Shaikh S, Sharma SK, Gupta S, Bhattacharyya S, Mohan V, Gunupati VK. Singh AK, et al. Among authors: thacker h. J Assoc Physicians India. 2023 Dec;71(12):62-74. doi: 10.59556/japi.71.0422. J Assoc Physicians India. 2023. PMID: 38736056
3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial.
le Roux CW, Astrup A, Fujioka K, Greenway F, Lau DCW, Van Gaal L, Ortiz RV, Wilding JPH, Skjøth TV, Manning LS, Pi-Sunyer X; SCALE Obesity Prediabetes NN8022-1839 Study Group. le Roux CW, et al. Lancet. 2017 Apr 8;389(10077):1399-1409. doi: 10.1016/S0140-6736(17)30069-7. Epub 2017 Feb 23. Lancet. 2017. PMID: 28237263 Free article. Clinical Trial.
A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management.
Pi-Sunyer X, Astrup A, Fujioka K, Greenway F, Halpern A, Krempf M, Lau DC, le Roux CW, Violante Ortiz R, Jensen CB, Wilding JP; SCALE Obesity and Prediabetes NN8022-1839 Study Group. Pi-Sunyer X, et al. N Engl J Med. 2015 Jul 2;373(1):11-22. doi: 10.1056/NEJMoa1411892. N Engl J Med. 2015. PMID: 26132939 Free article. Clinical Trial.
208 results